Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymeric anticancer drugs with pH-controlled activation.

K Ulbrich1, T Etrych, P Chytil

  • 1Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovský Sq. 2, 162 06 Prague 6, Czech Republic. ulbrich@imc.cas.cz

International Journal of Pharmaceutics
|May 26, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Czechoslovak/Prague School of Immunology.

Folia microbiologica·2026
Same author

Chemosensitization of tumors via simultaneous delivery of STAT3 inhibitor and doxorubicin through HPMA copolymer-based nanotherapeutics with pH-sensitive activation.

Nanomedicine : nanotechnology, biology, and medicine·2023
Same author

Adaptable polymerization platform for therapeutics with tunable biodegradability.

Acta biomaterialia·2023
Same author

Size-switchable polymer-based nanomedicines in the advanced therapy of rheumatoid arthritis.

Journal of controlled release : official journal of the Controlled Release Society·2022
Same author

Functionalized hydrogel microparticles prepared by microfluidics and their interaction with tumour marker carbonic anhydrase IX.

Soft matter·2020
Same author

PCL-PEG graft copolymers with tunable amphiphilicity as efficient drug delivery systems.

Journal of materials chemistry. B·2020

New pH-sensitive polymer-doxorubicin (DOX) conjugates offer enhanced anticancer drug delivery. These targeted therapies activate within cancer cells, improving efficacy and reducing side effects compared to free DOX.

Area of Science:

  • Polymer Chemistry
  • Drug Delivery Systems
  • Oncology

Background:

  • Developing targeted drug delivery systems is crucial for improving cancer therapy efficacy.
  • pH-sensitive drug conjugates offer a strategy for site-specific drug activation within tumor microenvironments or cells.
  • Current polymer-doxorubicin (DOX) conjugates, like the clinically tested PK1 (PHPMA-DOX), show promise but can be improved.

Purpose of the Study:

  • To synthesize and characterize novel pH-sensitive polymer-DOX conjugates for enhanced anticancer therapy.
  • To evaluate the impact of polymer structure and spacer design on conjugate stability, activation, and efficacy.
  • To compare the in vivo antitumor activity of these new conjugates against free DOX and existing conjugates.

Main Methods:

  • Synthesis of novel pH-sensitive polymer-DOX conjugates with varying polymer backbones and drug-spacer linkages.

Related Experiment Videos

  • In vitro assessment of conjugate stability, pH-triggered DOX release, and cellular uptake.
  • In vivo evaluation of antitumor efficacy and pharmacokinetics in a T-cell lymphoma mouse model (EL4, C57BL/16).

    • Main Results:

    • The synthesized conjugates demonstrated pH-dependent stability and drug release profiles.
    • Cytotoxicity was significantly influenced by the polymer structure and the nature of the spacer arm.
    • In vivo studies showed significantly enhanced antitumor activity for the novel pH-sensitive conjugates compared to free DOX and PK1 in a murine T-cell lymphoma model.

    Conclusions:

    • Novel pH-sensitive polymer-DOX conjugates exhibit superior in vivo antitumor efficacy compared to free DOX and current clinical candidates.
    • The design of the polymer carrier and the drug-linker is critical for achieving effective site-specific cancer therapy.
    • These advanced conjugates represent a promising platform for developing more effective and targeted anticancer treatments.